$10.59
1.3214.24%
Pre-Market: Jul 17, 9:28 AM EDT
15 minutes delayed
Comments
Loading...
Benitec Biopharma
BNTCNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benitec Biopharma (NASDAQ:BNTC) Stock, Analyst Ratings, Price Targets, Forecasts
Benitec Biopharma Inc has a consensus price target of $15.75 based on the ratings of 4 analysts. The high is $30 issued by Piper Sandler on June 13, 2024. The low is $4 issued by HC Wainwright & Co. on September 23, 2022. The 3 most-recent analyst ratings were released by Leerink Partners, Piper Sandler, and JMP Securities on July 22, 2024, June 13, 2024, and April 22, 2024, respectively. With an average price target of $19.67 between Leerink Partners, Piper Sandler, and JMP Securities, there's an implied 85.71% upside for Benitec Biopharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Leerink Partners
Piper Sandler
JMP Securities
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Benitec Biopharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | 22.76% | Leerink Partners | Mani Foroohar | → $13 | Initiates | → Outperform | Get Alert |
| 06/13/2024 | Buy Now | 183.29% | Piper Sandler | Yasmeen Rahimi | → $30 | Initiates | → Overweight | Get Alert |
| 04/22/2024 | Buy Now | 51.09% | JMP Securities | Silvan Tuerkcan | $10 → $16 | Maintains | Market Outperform | Get Alert |
| 02/15/2024 | Buy Now | -5.57% | JMP Securities | Silvan Tuerkcan | $8 → $10 | Maintains | Market Outperform | Get Alert |
| 01/24/2024 | Buy Now | -24.46% | JMP Securities | Silvan Tuerkcan | $6 → $8 | Maintains | Market Outperform | Get Alert |
| 09/26/2023 | Buy Now | -43.34% | JMP Securities | Silvan Tuerkcan | $4 → $6 | Maintains | Market Outperform | Get Alert |
| 06/26/2023 | Buy Now | -62.23% | JMP Securities | Silvan Tuerkcan | → $68 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/18/2023 | Buy Now | -62.23% | JMP Securities | Silvan Tuerkcan | $68 → $68 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/18/2022 | Buy Now | -62.23% | JMP Securities | Silvan Tuerkcan | → $68 | Initiates | → Market Outperform | Get Alert |
| 09/23/2022 | Buy Now | -62.23% | HC Wainwright & Co. | Patrick Trucchio | $170 → $68 | Maintains | Buy | Get Alert |
| 02/17/2022 | Buy Now | -5.57% | HC Wainwright & Co. | Patrick Trucchio | → $170 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Benitec Biopharma (BNTC) stock?
The latest price target for Benitec Biopharma (NASDAQ:BNTC) was reported by Leerink Partners on July 22, 2024. The analyst firm set a price target for $13.00 expecting BNTC to rise to within 12 months (a possible 22.76% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Benitec Biopharma (BNTC)?
The latest analyst rating for Benitec Biopharma (NASDAQ:BNTC) was provided by Leerink Partners, and Benitec Biopharma initiated their outperform rating.
When was the last upgrade for Benitec Biopharma (BNTC)?
There is no last upgrade for Benitec Biopharma
When was the last downgrade for Benitec Biopharma (BNTC)?
There is no last downgrade for Benitec Biopharma.
When is the next analyst rating going to be posted or updated for Benitec Biopharma (BNTC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Benitec Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Benitec Biopharma was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Benitec Biopharma (BNTC) correct?
While ratings are subjective and will change, the latest Benitec Biopharma (BNTC) rating was a initiated with a price target of $0.00 to $13.00. The current price Benitec Biopharma (BNTC) is trading at is $10.59, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.